Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients
Anna Nurmi(University of Helsinki), Heli Nevanlinna(University of Helsinki), Kristiina Aittomäki(Helsinki University Hospital), Liisa M. Pelttari(University of Helsinki), Sini Lehto(University of Helsinki), Carl Blomqvist(University of Helsinki), Johanna Schleutker(University of Turku), Tuomas Heikkinen(University of Helsinki), Taru Muranen(Karolinska Institutet), Ralf Bützow(Helsinki University Hospital), Johanna I. Kiiski(University of Helsinki), Anne Kallioniemi(University of California, San Francisco)
Cited by 31
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k